Usefulness of dual-axis rotational coronary angiography in primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction

被引:0
|
作者
Hideaki Suwa
Yota Koyabu
Taichi Adachi
Akira Kawai
Kazuhiko Kotani
Shigeru Toyoda
Teruo Inoue
Toru Kato
机构
[1] National Hospital Organization Tochigi Medical Center,Department of Cardiovascular Medicine
[2] Dokkyo Medical University,Department of Cardiovascular Medicine
[3] National Hospital Organization Tochigi Medical Center,Department of Radiology
[4] Jichi Medical University,Division of Community and Family Medicine, Center for Community Medicine
[5] National Hospital Organization Tochigi Medical Center,Department of Clinical Research
来源
Heart and Vessels | 2021年 / 36卷
关键词
ST-elevation myocardial infarction; Primary percutaneous coronary intervention; Contrast medium; Radiation exposure; Rotational coronary angiography;
D O I
暂无
中图分类号
学科分类号
摘要
Several studies have shown that dual-axis rotational coronary angiography (DARCA) reduces contrast medium volume and radiation exposure compared to conventional coronary angiography (CCA). However, there are no studies comparing the safety and usefulness of DARCA in primary percutaneous coronary intervention (PCI) for patients with ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate the effects of DARCA on contrast medium volume, radiation exposure, time course of treatment, and adverse events in primary PCI for patients with STEMI. A total of 82 patients undergoing primary PCI were included in this study. Subjects were propensity matched to 41 patients in the CCA group and 41 in the DARCA group. Data were retrospectively collected from in-patient medical records and the contrast medium volume and radiation exposure (dose-area product, DAP) during the PCI procedure was compared between the two groups. Contrast medium volume [100.0 (82.5–115.0) vs 110 (102.5–127.5) ml, p = 0.018, r = 0.26] and DAP [113.4 (74.3–141.1) vs 138.1 (100.5–194.7) Gy cm2, p = 0.014, r = 0.27] were significantly lower in the DARCA group, compared with the CCA group. Door to device time (68.7 ± 26.1 vs 76.5 ± 44.2 min, p = 0.33) were comparable between the two groups. There were no adverse events requiring treatment reported in either groups. DARCA may reduce contrast medium volume and radiation exposure in primary PCI for patients with STEMI, and can be used safely, without delaying reperfusion of the infarct-related coronary artery.
引用
收藏
页码:621 / 629
页数:8
相关论文
共 50 条
  • [41] Prediction of cardiovascular mortality in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention
    Ergelen, Mehmet
    Gorgulu, Sevket
    Uyarel, Huseyin
    Norgaz, Tugrul
    Ayhan, Erkan
    Akkaya, Emre
    Soylu, Ozer
    Ugur, Murat
    Tezel, Tuna
    CORONARY ARTERY DISEASE, 2010, 21 (04) : 207 - 211
  • [42] Is Aspirin Loading Before Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction Necessary?
    Hiroshi Asanuma
    Masafumi Kitakaze
    Cardiovascular Drugs and Therapy, 2022, 36 : 1243 - 1245
  • [43] PRIMARY PAYER STATUS AND OUTCOMES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    Kolte, Dhaval
    Khera, Sahil
    Aronow, Wilbert
    Mujib, Marjan
    Palaniswamy, Chandrasekar
    Jain, Diwakar
    Sule, Sachin
    Frishman, William
    Ahmed, Ali
    Fonarow, Gregg
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A56 - A56
  • [44] Development of systems of care for ST-elevation myocardial infarction patients - The primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective
    Granger, Christopher B.
    Henry, Timothy D.
    Bates, W. Eric R.
    Cercek, Bojan
    Weaver, W. Douglas
    Williams, David O.
    CIRCULATION, 2007, 116 (02) : E55 - E59
  • [45] Treatment Effect of Percutaneous Coronary Intervention in Dialysis Patients With ST-Elevation Myocardial Infarction
    Kawsara, Akram
    Sulaiman, Samian
    Mohamed, Mohamed
    Paul, Timir K.
    Kashani, Kianoush B.
    Boobes, Khaled
    Rihal, Charanjit S.
    Gulati, Rajiv
    Mamas, A. Mamas
    Alkhouli, Mohamad
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (06) : 832 - 840
  • [46] Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction
    Eikelboom, John W.
    O'Donnell, Martin
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (01): : 91 - 92
  • [47] Using the Zwolle Risk Score at Time of Coronary Angiography to Triage Patients With ST-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention or Thrombolysis
    Parr, Christopher J.
    Avery, Lorraine
    Hiebert, Brett
    Liu, Shuangbo
    Minhas, Kunal
    Ducas, John
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (04):
  • [48] SAFETY OF SONOTHROMBOLYSIS AFTER PERCUTANEOUS CORONARY INTERVENTION FOR PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
    El Kadi, Soufiane
    Spoormans, Eva Marie
    Verouden, Niels J. W.
    Porter, Thomas Richard
    van Rossum, Albert C.
    Kamp, Otto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1083 - 1083
  • [49] Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention
    Larson, David M.
    Duval, Sue
    Sharkey, Scott S.
    Solie, Christopher
    Tschautscher, Craig
    Lips, Daniel L.
    Burke, M. Nicholas
    Steinhubl, Steven
    Henry, Timothy D.
    AMERICAN HEART JOURNAL, 2010, 160 (01) : 202 - 207
  • [50] Clopidogrel Pretreatment in ST-Elevation Myocardial Infarction Patients Transferred for Percutaneous Coronary Intervention
    Larson, David M.
    Duval, Sue
    Sharkey, Scott W.
    Solie, Christopher
    Unger, Barbara T.
    Henry, Timothy D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A58 - A58